Accumulation of stabilin‑1 positive macrophages in the early stage of gastric cancer is associated with short cumulative survival
Authors:
Open Access
- 16 January 2020
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 19 (3) , 2404-2412
Abstract
The scavenger receptor stabilin‑1 has been reported to be expressed by tumor‑associated macrophages (TAMs) and to facilitate tumor growth and metastasis in mouse models of breast carcinoma and melanoma. However, to the best of our knowledge, its expression and association with prognosis in human gastric cancer has not been evaluated. The present study investigated the expression of stabilin‑1 and its association with clinicopathological parameters in patients with gastric cancer. The expression of stabilin‑1 was evaluated by immunohistochemical staining of gastric cancer tissue samples of 371 Chinese patients with primary gastric adenocarcinoma. Confocal laser scanning microscopy was used to determine the cellular source of stabilin‑1 in the gastric cancer tissues using anti‑CD68, anti‑CD163, anti‑stabilin‑1 and anti‑secreted protein acidic and rich in cysteine antibodies. A higher number of stabilin‑1‑positive cells were observed in the cancer tissues of primary gastric adenocarcinoma compared with adjacent non‑cancerous tissues of primary gastric adenocarcinoma (P<0.001); the majority of stabilin‑1‑positve cells were CD68+/CD163+ macrophages. Poorly‑differentiated gastric cancer tissue had fewer stabilin‑1‑positive cells compared with medium‑ and well‑differentiated gastric cancer (P=0.030). A higher number of stabilin‑1‑positive cells were found in the early Tumor‑Node‑Metastasis (TNM) stage (TNM I stage) of primary gastric adenocarcinoma (P=0.038) compared with TNM stage IV. For patients with TNM stage I disease, a higher number of stabilin‑1‑positive TAMs was associated with shorter cumulative survival (P<0.05). Overall, stabilin‑1 was found to be expressed by CD68+ TAMs in human gastric cancer. The high expression of stabilin‑1 in TNM stage I disease was associated with poor patient survival, indicating the clinical significance of stabilin‑1 in gastric cancer.Keywords
This publication has 31 references indexed in Scilit:
- The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patientsJournal of Cellular and Molecular Medicine, 2013
- Tumor-associated macrophages: functional diversity, clinical significance, and open questionsSeminars in Immunopathology, 2013
- Stabilin-1 expression in tumor associated macrophagesBrain Research, 2012
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patientsBMC Cancer, 2012
- The Role of SPARC Protein Expression in the Progress of Gastric CancerPathology and Oncology Research, 2012
- Type and location of tumor‐infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patientsInternational Journal of Cancer, 2011
- Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityExperimental Biology and Medicine, 2011
- SPARC Is Associated with Gastric Cancer Progression and Poor Survival of PatientsClinical Cancer Research, 2010
- Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancerEndocrine-Related Cancer, 2008
- Lymphatic endothelium‐specific hyaluronan receptor LYVE‐1 is expressed by stabilin‐1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesisThe Journal of Pathology, 2006